Trials / Completed
CompletedNCT00639496
Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis International Group Exploring NAC I Annual Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 184 (actual)
- Sponsor
- Zambon SpA · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether NAC added to prednisone, and azathioprine has a better effect on lung function, radiology and clinical condition than placebo + prednisone in combination with azathioprine after 6 and 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | n-acetylcysteine | 600 mg x 3, for 12 months |
| DRUG | placebo | Placebo |
Timeline
- Start date
- 2000-03-01
- Primary completion
- 2003-07-01
- Completion
- 2003-07-01
- First posted
- 2008-03-20
- Last updated
- 2015-03-05
Locations
7 sites across 7 countries: Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT00639496. Inclusion in this directory is not an endorsement.